Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
Theranostics
; 12(2): 657-674, 2022.
Article
in En
| MEDLINE
| ID: mdl-34976206
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Resorcinols
/
Endothelium, Vascular
/
Corneal Neovascularization
/
MAP Kinase Kinase Kinases
/
Lactones
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Theranostics
Year:
2022
Type:
Article
Affiliation country:
Australia